Chairman and CEO of C.R. Bard Inc. (BCR, Financial) Timothy M Ring sells 14,147 shares of BCR on 11/02/2009 at an average price of $75.25 a share.
C.R. Bard Inc. is one of the worldwide leaders in developing manufacturing and supplying healthcare products that focus on Vascular Urology and Oncology Disease States. In addition Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair performance irrigation hemostasis and other areas. C.r. Bard Inc. has a market cap of $7.41 billion; its shares were traded at around $75.88 with a P/E ratio of 15.5 and P/S ratio of 3. The dividend yield of C.r. Bard Inc. stocks is 0.9%. C.r. Bard Inc. had an annual average earning growth of 14.5% over the past 10 years. GuruFocus rated C.r. Bard Inc. the business predictability rank of 3-star.
BCR is in the portfolios of Richard Aster Jr of Meridian Fund, Ken Heebner of CAPITAL GROWTH MANAGEMENT LP.
C.R. Bard Inc. is one of the worldwide leaders in developing manufacturing and supplying healthcare products that focus on Vascular Urology and Oncology Disease States. In addition Bard offers a complete line of advanced Surgical Specialty products and services that address needs in hernia repair performance irrigation hemostasis and other areas. C.r. Bard Inc. has a market cap of $7.41 billion; its shares were traded at around $75.88 with a P/E ratio of 15.5 and P/S ratio of 3. The dividend yield of C.r. Bard Inc. stocks is 0.9%. C.r. Bard Inc. had an annual average earning growth of 14.5% over the past 10 years. GuruFocus rated C.r. Bard Inc. the business predictability rank of 3-star.
BCR is in the portfolios of Richard Aster Jr of Meridian Fund, Ken Heebner of CAPITAL GROWTH MANAGEMENT LP.
Insiders' Positions with BCR
- Sell:: Chairman and CEO Timothy M Ring sold 14,147 shares of BCR stock on 10/01/2009 at the average price of 78.12, the price of the stock has decreased by 2.87% since
- Sell:: Chairman and CEO Timothy M Ring sold 14,147 shares of BCR stock on 09/01/2009 at the average price of 80.55, the price of the stock has decreased by 5.8% since
- Sell:: Chairman and CEO Timothy M Ring sold 14,147 shares of BCR stock on 08/03/2009 at the average price of 74, the price of the stock has increased by 2.54% since
- Sell:: Chairman and CEO Timothy M Ring sold 14,147 shares of BCR stock on 07/01/2009 at the average price of 74.24, the price of the stock has increased by 2.21% since
- Sell:: Chairman and CEO Timothy M Ring sold 14,147 shares of BCR stock on 06/01/2009 at the average price of 71.65, the price of the stock has increased by 5.9% since
Insiders' Positions with BCR
- Sell:: Director Gail K Naughton sold 418 shares of BCR stock on 10/26/2009 at the average price of 75.62, the price of the stock has increased by 0.34% since
- Sell:: President and COO John H Weiland sold 36,590 shares of BCR stock on 09/01/2009 at the average price of 80.51, the price of the stock has decreased by 5.75% since
- Sell:: Group Vice President Jim C Beasley sold 500 shares of BCR stock on 08/31/2009 at the average price of 80.54, the price of the stock has decreased by 5.79% since
- Sell:: Group Vice President Brian P Kelly sold 10,501 shares of BCR stock on 08/27/2009 at the average price of 78.45, the price of the stock has decreased by 3.28% since
- Sell:: VP and Controller Frank Jr Lupisella sold 902 shares of BCR stock on 08/04/2009 at the average price of 74.92, the price of the stock has increased by 1.28% since
